RCUS

BIB Biotechnology GILD RCUS Uncategorized

Arcus downgraded at Morgan Stanley on balanced risk-reward setup

Jan 8, 2026

ABVX Biotechnology CGON CNTA JANX LLY MDGL RCUS RVMD SLDB Uncategorized

Here are the most and least likely M&A targets in biotech, according to Truist

Dec 23, 2025

Biotechnology CGEN GILD RCUS Uncategorized

Gilead and Arcus halt late-stage study for anti-TIGIT cancer drug

Dec 12, 2025